Actos bladder cancer blog | actos bladder cancer lawsuit

Actos Bladder Cancer Blog

Posted on Apr 11, 2012 By Jackson Allen Williams

Study results released on March 31, 2012 showed that Actos (piaglitazone) use was significantly associated with an increased risk of bladder cancer. The study used data from teh French national health …

Continue reading “New French Study Confirms Link Between Actos and Bladder Cancer” »

Posted on Feb 16, 2012 By Jackson Allen Williams

Earlier this week, United States District Judge for the Western District of Louisiana Rebecca Doherty entered an Order laying out deadlines for initial pretrial procedures for the Actos MDL . …

Continue reading “Initial Status Conference for Actos MDL Scheduled” »

Posted on Jan 24, 2012 By Jackson Allen Williams

On January 23, 2012, Judge Rebecca Doherty entered the First General Order – All Actions, in the Actos/Bladder Cancer MDL. In this Order, the Judge issued a stay on any discovery proceedings or …

Continue reading “Judge Enters First Order in Actos MDL” »

Posted on Jan 3, 2012 By Jackson Allen Williams

On December 29, 2011, the Judicial Panel on Multidistrict Litigation (“JPML”) ordered that all cases involving the diabetes medication, Actos and bladder cancer, be consolidated in an MDL in …

Continue reading “Actos Cases Consolidated in Western District of Louisiana MDL” »

Posted on Dec 1, 2011 By Jackson Allen Williams

The hearing regarding creating an Actos MDL was slated to be held today in Savannah, Georgia in front of the Judicial Panel on Multidistrict Litigation. An MDL is a consolidation of all federal …

Continue reading “Hearing Today on Potential Actos MDL” »

Posted on Nov 3, 2011 By Jackson Allen Williams

The United States Judicial Panel on Multidistrict Litigation has set for hearing Plaintiffs’ motion for centralization of all lawsuits filed regarding use of Actos and bladder cancer . Several …

Continue reading “Judicial Panel to Rule on Creation of Actos MDL as early as December” »

Posted on Aug 18, 2011 By Jackson Allen Williams

On July 21, 2011 the European Medicines Agency recommeded new contraindications and warnings for Actos (piolglitazone) to reduce increased risk of bladder cancer. The Agency, after review of recent …

Continue reading “European Medicines Agency Recommends New Warnings for Actos Bladder Cancer Risk” »

Posted on Aug 11, 2011 By Actos Bladder Cancer Attorney

We are pleased to announce the launch of our Actos Bladder Cancer Blog .

Continue reading “Welcome to our Actos Bladder Cancer Blog” »

Leave a Reply

Your email address will not be published. Required fields are marked *